Insider trades
Gary Patou, Director of Xenon Pharmaceuticals XENE, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $70.3K. The latest trade was on 06/05.
Gary Patou
Director
- Company
- Xenon Pharmaceuticals XENE
- First filing
- 23/06/02
- Trades
- 31 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$70.3K
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/05 | 06/08 | 1,322 sh | $53.14 | $70,251.08 | −5.0% | |
XENE | Open-market sale | 24/11/22 | 24/11/22 | 4,891 sh2 trades | $41.08avg. | $200,946.61 | −17.2% |
XENE | Open-market saleAmendment | 23/12/13–23/12/14 | 23/12/15 | 26,576 sh5 trades | $40.30avg. | $1,070,880.78 | No record |